2017
DOI: 10.1111/nan.12445
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study

Abstract: Overall, we found that the neuroinflammatory pathological markers in late stage AD human tissue to have a similar pattern in both EOAD and LOAD, though the severity of the pathological markers in the younger group was higher. Understanding the age effect in AD will be important when testing modifying agents that act on the neuroinflammation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
49
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(55 citation statements)
references
References 56 publications
6
49
0
Order By: Relevance
“…Interestingly, some studies demonstrate that the antiinflammatory effect of exercise in AD was attributed to the clearance of amyloid plaques [23], the plaques being a trigger of inflammation. Activated microglia and reactive astrocytes are identified as inflammatory pathology markers in AD [33]. In this study, we showed a decrease in microglial activation in the frontal cortex and hippocampus after resistance training, accompanied by a decrease in the activation of astrocytes in the DG region of the hippocampus.…”
Section: Discussionsupporting
confidence: 58%
“…Interestingly, some studies demonstrate that the antiinflammatory effect of exercise in AD was attributed to the clearance of amyloid plaques [23], the plaques being a trigger of inflammation. Activated microglia and reactive astrocytes are identified as inflammatory pathology markers in AD [33]. In this study, we showed a decrease in microglial activation in the frontal cortex and hippocampus after resistance training, accompanied by a decrease in the activation of astrocytes in the DG region of the hippocampus.…”
Section: Discussionsupporting
confidence: 58%
“…Their regional distribution follows that of the pathologic changes in AD. Recent studies indicate that the age of the individual also plays a role in microglial pathogenesis (63). The presence of microglia can be both detrimental and beneficial to AD pathogenesis.…”
Section: Microglia Heterogeneity and Admentioning
confidence: 99%
“…40,41 Reassuringly, a recent postmortem investigation of microglial activation measured morphologically in the brains of 11 late onset AD subjects vs. 12 age-matched controls also found increases in microglial activation in cortical but not sub-cortical regions. 4 Second, we have a limited sample size for genome-wide analyses, although it was sufficient to discover the rs2997325 variant which has a strong effect on both microglial activation and in vivo imaging. Third, our moderate sample size also means that we cannot exclude that activated microglia may have weak, undetected effects on non-AD pathologies.…”
Section: Discussionmentioning
confidence: 99%
“…Recent postmortem studies have shown that microglial densities in specific regions are associated with a syndromic diagnosis of both early and late-onset AD, 4 and a recent systematic review of 113 studies quantifying microglial activation in postmortem AD brain highlighted the importance of activation vs. abundance of these cells in disease. 5 However, low sample sizes, indirect measures of microglia, and lack of full antemortem and postmortem pathological assessments all limit the insights that can be drawn from the component studies and this systematic review.…”
Section: Introductionmentioning
confidence: 99%